Literature DB >> 16075121

Novel coordination polymers and structural systematics in the hydrothermal M,M' trans-3(-3-pyridyl)acrylic acid system.

Noel S Gunning1, Christopher L Cahill.   

Abstract

The bifunctional ligand trans-3-(3-pyridyl)acrylic acid has been utilized to promote the formation of a novel hetero-metallic [Cu3(C8H6NO2)6Nd2(NO3)6] (1) and two homometallic: [Nd(C8H6NO2)3H2O] (2) and [Cu(C8H6NO2)2] x H2O (3) metal organic framework (MOF) materials. The philosophy here is that a mixture of hard (Nd3+) and softer metal cations will show preference for the carboxylic and pyridyl functional groups, respectively. As such, a 3-D topology 1 has emerged as a stable, heterometallic structure. Efforts to explore structural systematics in this system have led to the synthesis of homometallic end members and hence the formation of a 2-D coordination polymer 2, and a 1-D coordination polymer 3. Presented is an analysis of the effect of a second metal centre on coordination environment, overall structure formation, thermal and luminescence properties.

Entities:  

Year:  2005        PMID: 16075121     DOI: 10.1039/b504862a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  catena-Poly[[aqua-[3-(3-pyrid-yl)acrylato]gadolinium(III)]-bis-[μ-3-(3-pyrid-yl)acrylato]].

Authors:  Zhi-Hui Qiu; Fu-Pei Liang; Qing-Feng Ruan; Zi-Lu Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-05-10

2.  Tetrakis[μ-3-(3-pyridyl)acrylato-κO:O']bis{(1,10-phenanthroline-κN,N')[3-(3-pyridyl)acrylato-κO,O']europium(III)} pentahydrate.

Authors:  Chong-Bo Liu; Hui-Liang Wen; Fang Deng; Jun-Hui Zuo
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2007-12-18

3.  Poly[[μ(3)-3-(3-pyrid-yl)acrylato-κN:O:O'][μ(2)-3-(3-pyrid-yl)acrylato-κO,O':O][μ(2)-3-(3-pyrid-yl)acrylato-κO:O')]gadolinium(III)].

Authors:  Zhi-Hui Qiu; Fu-Pei Liang; Qing-Feng Ruan; Zi-Lu Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.